457 (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint 457 is Beige, Elliptical/Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Caraco Pharmaceutical Laboratories.

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 457

Carbidopa and levodopa extended release 50 mg / 200 mg 457

Carbidopa and Levodopa Extended Release

Imprint: 457
Strength: 50 mg / 200 mg
Color: Beige
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Dopaminergic antiparkinsonism agents
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Caraco Pharmaceutical Laboratories
National Drug Code (NDC): 62756-0457
Inactive Ingredients: microcrystalline cellulose, silicon dioxide, hydroxypropyl cellulose (type l), ferric oxide red, D&C Yellow No. 10, hypromelloses, magnesium stearate
Note: Inactive ingredients may vary.